Health
We’re trimming a 2025 top gainer, taking profits on the market’s rotation into health stocks
We are selling 75 shares of GE Healthcare at roughly $90 each. Following Monday’s trade, Jim Cramer’s Charitable Trust will own 900 shares of GEHC, decreasing its weighting to about 2.25% from 2.42%. We’re taking advantage of the market’s rotation into health-care stocks by locking in profits in GE Healthcare. Following an up-and-down 2024, GE […]
Read More
Strategas sees health care outperforming in 2025
The health care sector is poised to see a rebound and lead the market this year, according to Strategas analysts, in part because some of the biggest players in the market have been beaten down by regulatory concerns over the last two years. “Health care’s weight in the S & P is at its lowest […]
Read More
UnitedHealthcare taps company veteran Tim Noel as new CEO following Brian Thompson killing
UnitedHealthcare (UHC) health insurance company signage is displayed on an office building in Phoenix, Arizona on July 19, 2023. Patrick T. Fallon | Afp | Getty Images UnitedHealthcare on Thursday tapped company veteran Tim Noel as its new CEO following the targeted killing of its former top executive, Brian Thompson, in Manhattan in December. Noel […]
Read More
A norovirus vaccine could be on the horizon as cases rise
A researcher works in the lab at the Moderna Inc. headquarters in Cambridge, Massachusetts, US, on Tuesday, March 26, 2024. Adam Glanzman | Bloomberg | Getty Images Norovirus is raging across the U.S. this winter. Moderna might soon have a vaccine for it. A large phase three trial of the shot is underway, with results […]
Read More
Our 5 top-performing portfolio stocks since December’s Monthly Meeting are tech free
It’s been a topsy-turvy start to 2025 for the stock market. Since the Club’s December Monthly Meeting, Wall Street has been barraged by headlines that sent equities seesawing down and then up. The S & P 500 wrapped up 2024 with a roughly 23% gain despite tumbling in the final four sessions of the year and […]
Read More
Healthy Returns: Biotech and pharma M&A is off to a good start in 2025 — but will it last?
The New York Stock Exchange welcomes Johnson & Johnson (NYSE: JNJ) on Dec. 5th, 2023. NYSE Group A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. I’m back in New York City after spending nearly a […]
Read More
FDA approves Johnson & Johnson’s nasal spray for depression as standalone treatment
This photo provided by Janssen Global Services shows Spravato nasal spray. Janssen Global Services via AP The Food and Drug Administration on Tuesday approved Johnson & Johnson‘s nasal spray to be used alone in adults with a major depressive disorder that is difficult to treat, as sales of the drug grow. The spray, called Spravato, […]
Read More
Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications
U.S. President Joe Biden speaks about prescription drug costs during an event at NHTI Concord Community College in Concord, New Hampshire, U.S., October 22, 2024. REUTERS/Elizabeth Frantz Elizabeth Frantz | Reuters The Biden administration on Friday unveiled the next 15 prescription drugs that will be subject to price negotiations between manufacturers and Medicare, kicking off […]
Read More
FDA officially authorizes Zyn nicotine pouches for sale following health review
Zyn nicotine cases and pouches are seen on a table in New York City on Jan. 29, 2024. Michael M. Santiago | Getty Images The U.S. Food and Drug Administration formally authorized Zyn nicotine pouches for sale after conducting an “extensive scientific review” about their safety. In a release Thursday, the agency said it had found the popular […]
Read More
Medicare’s new $2,000 cap on out-of-pocket drug costs could save enrollees thousands, AARP says
Most Medicare patients who hit the new $2,000 cap on out-of-pocket spending for prescription drugs could see massive savings, despite changes in premiums, according to a report released Thursday by AARP. The findings suggest the cap could be a huge benefit to older adults in Medicare who struggle to afford high-cost drugs for cancer, rheumatoid […]
Read More